SWATted away: the challenging experience of setting up a programme of SWATs in paediatric trials.


Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
19 Feb 2019
Historique:
received: 31 07 2018
accepted: 31 01 2019
entrez: 21 2 2019
pubmed: 21 2 2019
medline: 14 6 2019
Statut: epublish

Résumé

Randomised controlled trials are considered the best method for determining the effectiveness and safety of health interventions. Trials involving children are essential to ensure that treatments are safe and effective. However, many trials, in both adult and paediatric populations, do not achieve recruitment targets and/or maintain retention of participants, which can lead to a reduction in the internal and external validity of the results. Identifying ways of improving trial efficiency are important in order to increase the successful completion of trials. A 'Study Within A Trial' (SWAT) is a self-contained study embedded within an ongoing trial, which aims to establish evidence to improve the management and delivery of trials in healthcare. Increasing numbers of SWATs have been undertaken in recent years yet very few within paediatric trials. Herein, we describe some of the challenges with undertaking a programme of SWATs within paediatric clinical trials in the UK. The TRECA (TRials Engagement in Children and Adolescents) study involves developing multimedia websites for use within paediatric trials to provide recruitment information to children, young people and their families about the clinical trial. Challenges encountered included governance issues such as host trial approval processes and sharing of anonymised data, funding issues for host trials, internet quality and accessibility within the healthcare setting, and ethical concerns associated with SWAT methodology. We believe the ethical concerns are more pronounced in the paediatric setting, perhaps because of the fewer SWATs undertaken in these settings or that a more cautious, risk-averse approach to undertaking research with children is taken. SWATs are becoming increasingly common to provide an evidence base for methods to improve trial efficiency. However, we encountered a number of unanticipated challenges to embedding TRECA that have not been previously reported within the scientific literature. We believe that, if these issues were addressed through wider promotion and explanation of undertaking SWATs involving all key stakeholders, as well as by exploration of alternative funding models for SWATs, this would enable more streamlined, appropriate and timely processes for SWATs and a stronger evidence base for what works to increase trial efficiency. The TRECA study is registered on ISRCTN, ID 73136092 . Registered on 24 August 2016.

Sections du résumé

BACKGROUND BACKGROUND
Randomised controlled trials are considered the best method for determining the effectiveness and safety of health interventions. Trials involving children are essential to ensure that treatments are safe and effective. However, many trials, in both adult and paediatric populations, do not achieve recruitment targets and/or maintain retention of participants, which can lead to a reduction in the internal and external validity of the results. Identifying ways of improving trial efficiency are important in order to increase the successful completion of trials.
MAIN BODY METHODS
A 'Study Within A Trial' (SWAT) is a self-contained study embedded within an ongoing trial, which aims to establish evidence to improve the management and delivery of trials in healthcare. Increasing numbers of SWATs have been undertaken in recent years yet very few within paediatric trials. Herein, we describe some of the challenges with undertaking a programme of SWATs within paediatric clinical trials in the UK. The TRECA (TRials Engagement in Children and Adolescents) study involves developing multimedia websites for use within paediatric trials to provide recruitment information to children, young people and their families about the clinical trial. Challenges encountered included governance issues such as host trial approval processes and sharing of anonymised data, funding issues for host trials, internet quality and accessibility within the healthcare setting, and ethical concerns associated with SWAT methodology. We believe the ethical concerns are more pronounced in the paediatric setting, perhaps because of the fewer SWATs undertaken in these settings or that a more cautious, risk-averse approach to undertaking research with children is taken.
CONCLUSION CONCLUSIONS
SWATs are becoming increasingly common to provide an evidence base for methods to improve trial efficiency. However, we encountered a number of unanticipated challenges to embedding TRECA that have not been previously reported within the scientific literature. We believe that, if these issues were addressed through wider promotion and explanation of undertaking SWATs involving all key stakeholders, as well as by exploration of alternative funding models for SWATs, this would enable more streamlined, appropriate and timely processes for SWATs and a stronger evidence base for what works to increase trial efficiency.
TRIAL REGISTRATION BACKGROUND
The TRECA study is registered on ISRCTN, ID 73136092 . Registered on 24 August 2016.

Identifiants

pubmed: 30782209
doi: 10.1186/s13063-019-3236-4
pii: 10.1186/s13063-019-3236-4
pmc: PMC6381684
doi:

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

141

Subventions

Organisme : Department of Health
ID : HS&DR/14/21/21
Pays : United Kingdom
Organisme : Chief Scientist Office
ID : HSRU1
Pays : United Kingdom
Organisme : Health Services and Delivery Research Programme
ID : 14/21/21

Références

Pediatrics. 2012 Jun;129 Suppl 3:S118-23
pubmed: 22661757
Br J Psychiatry. 2016 Feb;208(2):189-94
pubmed: 26382948
Trials. 2018 Sep 10;19(1):481
pubmed: 30201022
Bull Med Ethics. 2004 Feb;(195):13-6
pubmed: 15812989
Trials. 2017 Jun 8;18(1):265
pubmed: 28595613
Lancet. 2016 Apr 9;387(10027):1573-1586
pubmed: 26423180
Ethics Behav. 1991;1(4):239-52
pubmed: 11651140
BMJ Open. 2017 Mar 20;7(3):e015276
pubmed: 28320800
Trials. 2018 Feb 23;19(1):139
pubmed: 29475444
Trials. 2014 Oct 25;15:407
pubmed: 25344684
Lancet. 2014 Jan 11;383(9912):166-75
pubmed: 24411645
BMJ Open. 2019 Jan 9;9(1):e023984
pubmed: 30782720
J Child Health Care. 2019 Sep;23(3):468-482
pubmed: 30384772
BMJ. 2015 Sep 25;351:h4923
pubmed: 26408289
Acad Med. 2011 Nov;86(11):1360-6
pubmed: 21952064
Cochrane Database Syst Rev. 2018 Feb 22;2:MR000013
pubmed: 29468635
Trials. 2016 Jan 14;17:27
pubmed: 26767365
BMC Med Res Methodol. 2010 Apr 30;10:38
pubmed: 20433728

Auteurs

Jacqueline Martin-Kerry (J)

Department of Health Sciences, University of York, Heslington, York, YO10 5DD, UK. jackie.martin-kerry@york.ac.uk.

Adwoa Parker (A)

Department of Health Sciences, University of York, Heslington, York, YO10 5DD, UK.

Peter Bower (P)

MRC North West Hub for Trials Methodology Research, NIHR School for Primary Care Research, University of Manchester, Manchester, M13 9PL, UK.

Ian Watt (I)

Department of Health Sciences and the Hull York Medical School, University of York, Heslington, York, YO10 5DD, UK.

Shaun Treweek (S)

Health Services Research Unit, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, UK.

David Torgerson (D)

Department of Health Sciences, University of York, Heslington, York, YO10 5DD, UK.

Catherine Arundel (C)

Department of Health Sciences, University of York, Heslington, York, YO10 5DD, UK.

Peter Knapp (P)

Department of Health Sciences and the Hull York Medical School, University of York, Heslington, York, YO10 5DD, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH